Chairman of the Board
Carl E. Berg is Co-Founder, Chairman of the Board and Principal Investor of BERG. Carl is one of the co-visionaries of Silicon Valley where he has been developing, leasing, owning and operated R&D and office buildings since 1963. Carl has built or owned over 15 million sq. feet of commercial real estate., Mr. Berg was the Chairman of the Board and CEO of Mission West Properties, Inc. From 1997 until its sale in 2012. Mission West Properties was a public real estate investment trust with Microsoft & Apple as major tenants.
Co-founder, President & Chief Executive Officer
Niven R. Narain is Co-Founder, President, & CEO of BERG. His foremost passion is to improve healthcare systems and patient care through the fusion of AI and patient biology to develop the next generation of therapeutics. As CEO, Niven drives the vision of the translational engine from discovery to clinical development and ensures that BERG is collaborating with like-minded institutions to advance product development. He discovered Interrogative Biology®, BERG’s flagship platform that has created a robust pipeline of products in cancer, diabetes, and CNS diseases. BPM 31510 is BERG’s lead asset in solid tumors which is currently in Phase II trials. He is inventor on over 600 issued and pending patents over a diverse range of assets in drugs and diagnostics.
David Butze serves as a board director to BERG. David is a former CEO and President of several Services Organizations. His experience includes C suite positions at public companies, leading an independent professional services firm and serving as president of the US unit of a worldwide telecommunications provider.
Major General Granger serves as a board director for BERG. He is currently the President and CEO of The 5Ps, LLC, a health care, education, and leadership consulting organization, Centennial, CO 80015 since August 6, 2009. Prior to his retirement from the US Army on July 1, 2009, MG Granger served as the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs), Washington, DC, from December 2005 to May 2009. In this role, he was the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DOD health plan policy and performance.
Eric J. Nestler serves as a board director for BERG. He is the Nash Family Professor of Neuroscience, Chairman of the Department of Neuroscience and Director of the Friedman Brain Institute at the Mount Sinai Medical Center in New York. His work in neuropsychopharmacology has been instrumental in forming a molecular approach to psychiatry and has furthered the understanding of the molecular basis of both depression and drug addiction, using animal models to study the way drug use or stress affects the brain. Dr. Nestler is the author of Neurobiology of Mental Illness and Molecular Neuropharmacology, and more than 400 chapters and peer-reviewed publications. He is active in six research projects funded by the National Institute on Drug Abuse and the National Institute of Mental Health.